The Issuer, StageZero Life Sciences Ltd., applied to the Ontario Securities Commission for a partial revocation of a failure-to-file cease trade order issued on April 8, 2024.
The Issuer sought the partial revocation to complete a private placement of up to $2,000,000 to raise funds to prepare its unfiled continuous disclosure documents, pay outstanding fees, and apply for a full revocation order.
The Commission granted the partial revocation order, subject to conditions including providing subscribers with a copy of the order and obtaining acknowledgements that the securities remain subject to the cease trade order.